Key Insights

Highlights

Treatment Research

1 treatments under study, led by Map3

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results0

Data Visualizations

Phase Distribution

1Total
P 4 (1)

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02161016Phase 4TerminatedPrimary

A Clinical Study of Outcomes in Foot and Ankle Bone Grafting Using map3® Cellular Allogeneic Bone Graft

Showing all 1 trials

Research Network

Common Treatments

  • Map31

Active Sponsors

  • Rti Surgical1

Related Conditions

  • Fracture Of Foot1
  • Disorder Of Joint Of Foot1
  • Deformity Of Bone1

Activity Timeline